Cited by 71Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology

Open access

Monsell, Sarah E., Mock, Charles, Hassenstab, Jason, Roe, Catherine M., Cairns, Nigel J., Morris, John C., Kukull, Walter·2014·Neurology

DOI 10.1212/wnl.0000000000000650PMC PMC4132573

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To determine whether asymptomatic persons with Alzheimer disease (AD) neuropathologic change differ in the trajectory of their cognitive performance compared to asymptomatic persons without AD neuropathologic change. METHODS: Longitudinal performance on standard neuropsychological tests was examined in participants who died within 2 years of their last cognitive assessment and who were never diagnosed with mild cognitive impairment or dementia (Clinical Dementia Rating global score of 0 at all assessments). Using cognitive and neuropathologic data collected between 2005 and 2013 from the 34 National Institute on Aging-sponsored Alzheimer's Disease Centers, cognitive trajectories were compared for persons with and without evidence of AD neuropathologic change. We evaluated rates of decline in 4 domains (episodic memory, language, attention/working memory, executive function). The significance of the differences (β) in rates of decline was tested using linear regression, adjusting for age, education, sex, and other neuropathologic lesions. RESULTS: Participants who had low to high levels of AD neuropathologic change (n = 131) showed a greater rate of decline on the attention/working memory domain score (β = -0.11; 95% confidence interval = -0.19, -0.02; p = 0.02) when compared to 80 participants who died without evidence of AD neuropathologic change. CONCLUSIONS: Clinically normal individuals who come to autopsy with AD neuropathologic change exhibit subtle evidence of declining cognitive trajectories for attention/working memory.

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000650

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citation
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Boston Naming Test
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citation
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
Reitan, R. M., & Wolfson, D. E. (1993) · Medical Entomology and Zoology · Cited by 3,413
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172

Show all 42 references

Research works printed but not linked: 1

Wechsler D. WMS-R: Wechsler Memory Scale–Revised Manual. Cleveland, OH: Psychological Corp., Harcourt Brace Jovanovich; 1987.

Sorted by citations

NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
“Clinicopathologic studies suggest that low levels of pathologic changes are associated with subtle cognitive deficits among CU persons [8,161].”
Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260
Cognitive impairment and decline in cognitively normal older adults with high amyloid‐β: A meta‐analysis
Baker, J. E., Lim, Y. Y., Pietrzak, R. H., Hassenstab, J. J., Snyder, P. J., Masters, C. L., & Maruff, P. T. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.09.002 · Cited by 214
Self-citation
Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease
James, B. D., & Bennett, D. A. (2019) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040218-043758 · Cited by 213
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility
Mortamais, M., Ash, J. A., Harrison, J., Kaye, J. A., Kramer, J. H., RANDOLPH, C. C., Pose, C., Albala, B., Ropacki, M. T., Ritchie, C. W., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.2365 · Cited by 212
AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure
Mishra, S., Gordon, B. A., Su, Y., Christensen, J. J., Friedrichsen, K. A., Jackson, K., Hornbeck, R. C., Balota, D. A., Cairns, N. J., Morris, J. C., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.07.050 · Cited by 178
Self-citation
Saccadic Eye Movement in Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Opwonya, J., Doan, D. N. T., Kim, S. G., Kim, J. I., Ku, B. U., Kim, S., Park, S., & Kim, J. U. (2021) · Neuropsychology Review · doi:10.1007/s11065-021-09495-3 · Cited by 156
Association of loneliness with 10-year dementia risk and early markers of vulnerability for neurocognitive decline
Salinas, J., Beiser, A. S., Samra, J. K., O'Donnell, A., DeCarli, C. S., Gonzales, M. M., Aparicio, H. J., & Seshadri, S. (2022) · Neurology · doi:10.1212/wnl.0000000000200039 · Cited by 127
Clinical Features of Alzheimer Disease With and Without Lewy Bodies
Chung, E. J., Babulal, G. M., Monsell, S. E., Cairns, N. J., Roe, C. M., & Morris, J. C. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0606 · Cited by 130
Self-citation
NIA commentary on the NIA‐AA Research Framework: Towards a biological definition of Alzheimer's disease
Silverberg, N. B., Elliott, C. L., Ryan, L. M., Masliah, E., & Hodes, R. J. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.03.004 · Cited by 112
The 5-HT2A serotonin receptor in executive function: Implications for neuropsychiatric and neurodegenerative diseases
Aznar, S., & Hervig, M. E.-S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.008 · Cited by 99
Brain Alterations and Clinical Symptoms of Dementia in Diabetes: Aβ/Tau-Dependent and Independent Mechanisms
Sato, N., & Morishita, R. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00143 · Cited by 84
Prediction of Incipient Alzheimer’s Disease Dementia in Patients with Mild Cognitive Impairment
Ardekani, B. A., Initiative, A. D. N., Bermudez, E., Mubeen, A. M., & Bachman, A. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160594 · Cited by 63
Quantifying brain metabolism from FDG‐PET images into a probability of Alzheimer's dementia score
Yee, E., Popuri, K., Beg, M. F., & Initiative, T. A. D. N. (2019) · Human Brain Mapping · doi:10.1002/hbm.24783 · Cited by 61
Can Intraoperative Processed EEG Predict Postoperative Cognitive Dysfunction in the Elderly?
Deiner, S. G., Luo, X., Silverstein, J. H., & Sano, M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.11.004 · Cited by 59
Behavioral and cognitive markers of mild cognitive impairment: diagnostic value of saccadic eye movements and Simon task
Chehrehnegar, N., Nejati, V., Shati, M., Esmaeili, M., Rezvani, Z., Haghi, M., & Foroughan, M. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01121-w · Cited by 57
Late-life memory trajectories in relation to incident dementia and regional brain atrophy
Zahodne, L. B., Wall, M. M., Schupf, N., Mayeux, R. P., Manly, J. J., Stern, Y., & Brickman, A. M. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7871-8 · Cited by 46
Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly
Oh, H., Steffener, J., Razlighi, Q. R., Habeck, C. G., Liu, D., Gazes, Y., Janicki, S. C., & Stern, Y. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.016 · Cited by 46
Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology
Hassenstab, J. J., Monsell, S. E., Mock, C., Roe, C. M., Cairns, N. J., Morris, J. C., & Kukull, W. A. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000254 · Cited by 40
Self-citation
Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease
Wroolie, T., Kenna, H. A., Williams, K. E., & Rasgon, N. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.05.009 · Cited by 39
How Does Psychosocial Behavior Contribute to Cognitive Health in Old Age?
Wilson, R., & Bennett, D. A. (2017) · Brain Sciences · doi:10.3390/brainsci7060056 · Cited by 39
Braak stage and trajectory of cognitive decline in noncognitively impaired elders
Mufson, E. J., Malek‐Ahmadi, M. H., Snyder, N. L., Ausdemore, J., Chen, K., & Perez, S. E. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.003 · Cited by 38
Cognitive composite score association with Alzheimer’s disease plaque and tangle pathology
Malek‐Ahmadi, M. H., Chen, K., Perez, S. E., He, A., & Mufson, E. J. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0401-z · Cited by 38
A six-month longitudinal evaluation significantly improves accuracy of predicting incipient Alzheimer's disease in mild cognitive impairment
Mubeen, A. M., Asaei, A., Bachman, A. H., Sidtis, J. J., & Ardekani, B. A. (2017) · Journal of Neuroradiology · doi:10.1016/j.neurad.2017.05.008 · Cited by 35
Subtle changes in daily functioning predict conversion from normal to mild cognitive impairment or dementia: an analysis of the NACC database
Nowrangi, M. A., Rosenberg, P. B., & Leoutsakos, J. (2016) · International Psychogeriatrics · doi:10.1017/s1041610216000995 · Cited by 35
The Utility of the National Alzheimer’s Coordinating Center’s Database for the Rapid Assessment of Evolving Neuropathologic Conditions
Mock, C., Teylan, M., Beecham, G. W., Besser, L. M., Cairns, N. J., Crary, J. F., Katsumata, Y., Nelson, P. T., & Kukull, W. A. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000380 · Cited by 34
Self-citation
Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management
Costa, M., & Páez, A. (2021) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2021.103164 · Cited by 32
Associations Between Retinal Nerve Fiber Layer and Ganglion Cell Layer in Middle Age and Cognition From Childhood to Adulthood
Barrett-Young, A., Ambler, A. P., Cheyne, K. R., Guiney, H., Kokaua, J., Steptoe, B., Tham, Y. C., Wilson, G., Wong, T. Y., & Poulton, R. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2021.6082 · Cited by 31
Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer’s Disease Prior to Overt Global Amyloid Positivity
Ali, D. G., Bahrani, A. A., Barber, J. M., Khouli, R. H. E., Gold, B. T., Harp, J. P., Jiang, Y., Wilcock, D. M., & Jicha, G. A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220294 · Cited by 32
Association between thyroid function and Alzheimer's disease: A systematic review
Figueroa, P. B. S., Ferreira, A. F. F., Britto, L. R., Doussoulin, A. P., & Torrão, A. D. S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00760-1 · Cited by 28
Biomarker-based signature of alzheimer's disease in pre-MCI individuals
Chipi, E., Salvadori, N., Farotti, L., & Parnetti, L. (2019) · Brain Sciences · doi:10.3390/brainsci9090213 · Cited by 27
Anti-aging Klotho Protects SH-SY5Y Cells Against Amyloid β1–42 Neurotoxicity: Involvement of Wnt1/pCREB/Nrf2/HO-1 Signaling
Sedighi, M., Baluchnejadmojarad, T., Afshin‐Majd, S., Amiri, M., Aminzade, M., & Roghani, M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01621-9 · Cited by 27
The Transcranial Light Therapy Improves Synaptic Plasticity in the Alzheimer’s Disease Mouse Model
Buendía, D., Guncay, T., Oyanedel, M., Lemus, M., Weinstein, A., Ardiles, Á. O., Marcos, J. L., Fernandes, A. B., Zângaro, R. A., & Muñoz, P. (2022) · Brain Sciences · doi:10.3390/brainsci12101272 · Cited by 26
Working memory test battery for young adults: Computerized working memory assessment
Ma, L., Chang, L., Chen, X., & Zhou, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175047 · Cited by 28
Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups
Zahodne, L. B., Schupf, N., Brickman, A. M., Mayeux, R. P., Wall, M. M., Stern, Y., & Manly, J. J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151114 · Cited by 23
Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease
Day, G. S., Musiek, E. S., Roe, C. M., Norton, J. B., Goate, A., Cruchaga, C., Cairns, N. J., & Morris, J. C. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1236 · Cited by 21
Self-citation
Souvenaid for Alzheimer's disease
Burckhardt, M., Watzke, S., Wienke, A., Langer, G., & Fink, A. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011679.pub2 · Cited by 19
Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
Ihara, R., Iwata, A., Suzuki, K., Ikeuchi, T., Kuwano, R., Iwatsubo, T., & Initiative, J. A. D. N. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.10.004 · Cited by 22
Temporal Order of Alzheimer’s Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies
Bilgel, M., Koscik, R. L., An, Y., Prince, J. L., Resnick, S. M., Johnson, S. C., & Jedynak, B. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170448 · Cited by 21
Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology
Monsell, S. E., Mock, C., Fardo, D. W., Bertelsen, S. E., Cairns, N. J., Roe, C. M., Ellingson, S. R., Morris, J. C., Goate, A., & Kukull, W. A. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000179 · Cited by 18
Self-citation
Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease
Harrington, K., Schembri, A. J., Lim, Y. Y., Dang, C., Ames, D. J., Hassenstab, J. J., Laws, S. M., Rainey‐Smith, S. R., Robertson, J. S., Rowe, C. C., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.005 · Cited by 17
Self-citation
Age Profiles of Cognitive Decline and Dementia in Late Life in the Aging, Demographics, and Memory Study
Walsh, C., Yang, Y. C., Oi, K., Aiello, A. E., Belsky, D. W., Harris, K. M., & Plassman, B. L. (2022) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbac038 · Cited by 16
Enhancing attention in neurodegenerative diseases: current therapies and future directions
Sharma, K., Davis, T. L., & Coulthard, E. J. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0016 · Cited by 16
Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis
Chiang, A. C. A., Fowler, S., Reddy, R., Pletniková, O., Troncoso, J. C., Sherman, M. A., Lesné, S., & Jankowsky, J. L. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.011 · Cited by 17
The Impact of Aging on Brain Pituitary Adenylate Cyclase Activating Polypeptide, Pathology and Cognition in Mice and Rhesus Macaques
Han, P., Nielsen, M., Song, M., Yin, J., Permenter, M. R., Vogt, J. A., Engle, J. R., Dugger, B. N., Beach, T. G., Barnes, C. A., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00180 · Cited by 12
Early symptoms of A lzheimer's disease in J apan and T aiwan
Yang, Y., Hsu, C., Chou, M., Kasai, M., Meguro, K., & Liu, C. (2015) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12557 · Cited by 12
Chocolate, Air Pollution and Children's Neuroprotection: What Cognition Tools should be at Hand to Evaluate Interventions?
Calderón‐Garcidueñas, L., Chávez, V. S. J., Vacaseydel-Aceves, N., Calderón-Sánchez, R., Escobedo, E. H. M., Frías, C., Giacometto, M., Velásquez, L., Félix-Villarreal, R., Martin, J. D., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00232 · Cited by 12
Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals
Collij, L. E., Mastenbroek, S. E., Salvadó, G., Wink, A. M., Visser, P. J., Barkhof, F., van Berckel, B. N. M., & Lopes Alves, I. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12216 · Cited by 17
Phosphorylated tau in Alzheimer’s disease
Telser, J., Grossmann, K., Wohlwend, N., Risch, L., Saely, C. H., & Werner, P. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2023.05.001 · Cited by 11
Beta-amyloid moderates the relationship between cortical thickness and attentional control in middle- and older-aged adults
McKay, N. S., Dincer, A., Mehrotra, V., Aschenbrenner, A. J., Balota, D. A., Hornbeck, R. C., Hassenstab, J. J., Morris, J. C., Benzinger, T. L. S., & Gordon, B. A. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.12.012 · Cited by 11
Self-citation
Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology
Hantke, N. C., Kaye, J., Mattek, N., Wu, C.-Y., Dodge, H. H., Beattie, Z., & Woltjer, R. (2023) · PLOS ONE · doi:10.1371/journal.pone.0286812 · Cited by 10
Modeling practice effects in healthy middle‐aged participants of the Alzheimer and Families parent cohort
Sánchez‐Benavides, G., Gispert, J. D., Fauria, K., Molinuevo, J. L., & Gramunt, N. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.07.001 · Cited by 10
Detrending Changes the Temporal Dynamics of a Semantic Fluency Task
Lenio, S., Lissemore, F. M., Sajatovic, M., Smyth, K. A., Tatsuoka, C. M., Woyczyński, W. A., & Lerner, A. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00252 · Cited by 8
Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic α4β2 Receptor Availability in Alzheimer’s Disease
Oboshi, Y., Kikuchi, M., Terada, T., Yoshikawa, E., Bunai, T., & Ouchi, Y. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151165 · Cited by 6
Ultra-Early Screening of Cognitive Decline Due to Alzheimer’s Pathology
Wei, P. (2023) · Biomedicines · doi:10.3390/biomedicines11051423 · Cited by 7
Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer’s disease
Argiris, G., Akinci, M., Peña-Gómez, C., Palpatzis, E., Garcia-Prat, M., Shekari, M., Blennow, K., Zetterberg, H., Kollmorgen, G., Quijano-Rubio, C., et al. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01629-y · Cited by 6
Bioinformatic analysis of hippocampal histopathology in Alzheimer’s disease and the therapeutic effects of active components of traditional Chinese medicine
Zhiyan, C., Min, Z., Yida, D., He, C., Hu, X., Yutong, L., Huan, W., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1424803 · Cited by 5
Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals
Sannemann, L., for the DELCODE Study Group, Bartels, C., Brosseron, F., Büerger, K., Fließbach, K., Freiesleben, S. D., Frommann, I., Glanz, W., Heneka, M. T., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231335 · Cited by 6
Possibility of Using Quantitative Assessment with the Cube Copying Test for Evaluation of Visuo-spatial Function in Patients with Alzheimer’s Disease
Mori, S., Osawa, A., Maeshima, S., Sakurai, T., Ozaki, K., Kondo, I., & Saitoh, E. (2021) · Progress in Rehabilitation Medicine · doi:10.2490/prm.20210021 · Cited by 4
Exposure to static magnetic field facilitates selective attention and neuroplasticity in rats
Wang, T., Yasin, N., Zubedat, S., Loboda, Y., Avital, A., Schächter, L., & Finberg, J. P. M. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.08.016 · Cited by 4
Attentional Functioning in Healthy Older Adults and aMCI Patients: Results from the Attention Network Test with a Focus on Sex Differences
Facci, L., Sandrini, L., & Bottini, G. (2025) · Brain Sciences · doi:10.3390/brainsci15070770 · Cited by 3
Impaired Affordance Perception as the Basis of Tool Use Deficiency in Alzheimer’s Disease
Kim, N.-G., Effken, J. A., & Lee, H. (2022) · Healthcare · doi:10.3390/healthcare10050839 · Cited by 2
Souvenaid for Alzheimer's disease
Burckhardt, M., Herke, M., Wustmann, T., Fink, A. M., Watzke, S., & Langer, G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011679 · Cited by 2
Early sensory deficits in Alzheimer’s disease: A review of potential integrating diagnostic methods
Yang, Y. (2024) · Journal of Clinical and Translational Science · doi:10.1017/cts.2024.525 · Cited by 2
Subjective Cognitive Decline and Antisaccade Latency: Exploring Early Markers of Dementia Risk
Wilcockson, T. D. W., Begde, A., & Hogervorst, E. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2020016 · Cited by 1
Impact of the New Conceptual Framework of Alzheimer’s Disease in Imaging Studies
Dubois, B., Villain, N., Jacova, C., & Uspenskaya, O. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_13 · Cited by 1
Alzheimer’s Disease and white matter
Filley, C. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781139548878.016
Biomarcadores moleculares e de neuroimagem em pacientes com comprometimento cognitivo leve
Magalhães, T. N. C. (2021) · doi:10.47749/t/unicamp.2021.1165434
Personalized Metabolic Modelling Reveals Molecular Characteristics of Asymptomatic Alzheimer's Disease
Lüleci̇, H. B., & Çakır, T. (2025) · International Artificial Intelligence and Data Processing Symposium (IDAP) · doi:10.1109/idap68205.2025.11222180
Unravelling Synaptic and Metabolic Mechanisms of Cognitive Resilience in Asymptomatic Alzheimer’s Disease Across Two Alzheimer’s Disease Cohorts
Aksu, R., Lüleci̇, H. B., & Çakır, T. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01700-2 · Cited by 1
Aloe emodin attenuates Aβ 1–42 -Induced neurotoxicity in SH-SY5Y cells via downregulation of PPM1K
Huang, F., Guo, M., Yang, Y., & Wang, Z. (2026) · Open Medicine · doi:10.1515/med-2026-1473

Authors: Monsell, S. E., Mock, C., Hassenstab, J., Roe, C. M., Cairns, N. J., Morris, J. C., & Kukull, W.
Affiliations: University of Washington (US)
ORCID: Monsell, Sarah E.
Mock, Charles
Hassenstab, Jason
Roe, Catherine M.
Cairns, Nigel J.
Morris, John C.
Kukull, Walter
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-07-29
Volume: 83
Issue: 5
Pages: 434-440
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0000000000000650
PMC: PMC4132573
OpenAlex: W1974806875
Cited by: 71
References: 42
Citations by year: 2026: 2 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 8 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 7 · 2016: 15 · 2015: 8 · 2014: 1
FWCI: 7.89
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Neurology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (U01AG016976, P50AG005681, P01AG003991, P01AG026276)
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK094982)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords: Alzheimer's disease, cognitive decline, episodic memory, language, executive function, autopsy, longitudinal cognitive trajectories
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Asymptomatic Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks